Neurology® Podcast

Dr. Alex Menze talks with Dr. Kathryn C. Fitzgerald about using accelerometry to detect subtle, longitudinal changes in disability in people with multiple sclerosis and how these changes relate to brain atrophy and disability progression.  Read the related article in Neurology®.  Disclosures can be found at Neurology.org. 

Dr. Katie Krulisky talks with Dr. Cristina Domínguez-González about the complexities of mitochondrial disease, including diagnosis, biomarkers, and recent research on POLG-related disorders.  Read the related article in Neurology® Genetics.  Disclosures can be found at Neurology.org.

Dr. Stacey Clardy talks with Drs. Deborah Hall and Deborah Setter about the current situation for lactating individuals in neurology and the opportunities for improvement in the workplace.  Read the related article in Neurology® Clinical Practice.  Disclosures can be found at Neurology.org. 

The May 2026 Recall highlights four in‑depth conversations focused on the clinical approach to monocular vision loss. The episode opens with Dr. Dan Ackerman leading a two-part series with Drs. Valérie Biousse and Nancy J. Newman on the challenges and opportunities in diagnosing CRAO and BRAO. The episode continues with a second, two‑part series in which Dr. Justin Abbatemarco speaks with Drs. Valérie Biousse and Nancy J. Newman about updates in non‑arteritic ischemic optic neuropathy. Podcast links: Challenges and Opportunities in Diagnosing CRAO/BRAO - Part 1 Challenges and Opportunities in Diagnosing CRAO/BRAO - Part 2 Updates in Non-Arteritic Ischemic Optic Neuropathy - Part 1  Updates in Non-Arteritic Ischemic Optic Neuropathy - Part 2  Related article: Eye Stroke Protocol in the Emergency Department  Disclosures can be found at Neurology.org. 

Dr. Zohaib Siddiqi talks with Dr. Laurence Poirier about a complex stroke case associated with systemic vasculitis, highlighting diagnostic challenges and management strategies, including the role of endovascular therapy.  Read the related Resident & Fellow Section article in Neurology®. Disclosures can be found at Neurology.org. 

Dr. Jeff Ratliff talks with Dr. John W. Winkelman about the new clinical practice guidelines for treating restless legs syndrome and periodic limb movement disorder, covering diagnosis, treatment options, and future management insights. Read the related article in the Journal of Clinical Sleep Medicine. Disclosures can be found at Neurology.org. 

1. Brain death, the determination of brain death, and member guidance for brain death accommodation requests: AAN position statement. 2. [What's Trending]: On tau protein and Alzheimer dementia symptoms. In the first segment, Dr. Jason Crowell talks with Dr. James Russell about his paper on brain death, the determination of brain death, and member guidance for brain death accommodation requests. In the second part of the podcast, Dr. Jeff Burns focuses his interview with Dr. Matthew Brier on tau protein and Alzheimer dementia symptoms.DISCLOSURES: Dr. Jason Crowell reports no disclosures. Dr. James Russell has served on Scientific Advisory Boards for Cytokinetics - Data Monitoring Board PROTOCOL CY 5022 A PHASE 2, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, DOSE- RANGING, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF CK-2127107 IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS). Dr. James Russell received travel funding from 1) Non-profit - Mexican Academy of Neurology - Funded travel and lodging to speak at Annual Meeting Nov 2018 - no honorarium (2) Non-profit - ALS Association - funded travel and lodging to do site visit for ALSA certification of UVA ALS Clinic. Dr. James Russell has publishing royalties from (1) Neuromuscular Disorders, McGraw-Hill, 2nd edition published 2015, with subsequent royalities 2) Honorarium for published article in Continuum: Approach to peripheral neuropathy. Continuum: Peripheral Nervous System Disorders. Fall 2017. Dr. James Russell has done consultancies with compensation for market research interviews regarding ALS therapeutics and is currently being compensated for expert opinion in two medical legal cases, one in support of the defendant and one in support of the plaintiff. Dr. Matthew Brier has received funding for Biogen, travel and accommodation and received research support for Medical Scientist Training Program Grant to WUSTL (5T32GM007200-37.